BCRX
BioCryst Pharmaceuticals, Inc.
$7.30−0.20 (−2.67%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Mar 4, 1994 – Nov 18, 2026, Dividends reinvested
- Final balance
- $11,231
- CAGR
- +0.36%
- Max drawdown
- −97.74%
Trailing returns (%)
BCRX's average annual return was 2.01% over the last 10 years and −2.34% over the last 20 years, through Nov 18, 2026. $10,000 in BCRX on Nov 18, 2016 grew to $12,207 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- −6.29%
- 3M
- −24.74%
- 6M
- −18.62%
- YTD
- −6.41%
- 1Y
- +4.29%
Per year
- 3Y
- +10.91%
- 5Y
- −9.08%
- 10Y
- +2.01%
- 15Y
- +6.55%
- 20Y
- −2.34%
- 25Y
- +2.68%
- 30Y
- −2.15%
- Since 1994
- +0.36%
Annual returns
1994 from Mar 4 · 2026 through Nov 18
BCRX returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | −6.41% |
| 2025 | +3.72% |
| 2024 | +25.54% |
| 2023 | −47.82% |
| 2022 | −17.11% |
| 2021 | +85.91% |
| 2020 | +115.94% |
| 2019 | −57.25% |
| 2018 | +64.36% |
| 2017 | −22.43% |
| 2016 | −38.66% |
| 2015 | −15.13% |
Metrics
Since 1994| Volatility | 81.91% |
|---|---|
| Sharpe ratio | 0.42 |
| Sortino ratio | 0.65 |
| Calmar ratio | 0.00 |
| Longest drawdown | 26.2 years |
Worst drawdowns
Since 1994| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −97.7% | Aug 2000 | Jul 2002 | Not yet | 26.2 years so far |
| −76.0% | Jun 1996 | Oct 1998 | Aug 1999 | 3.1 years |
| −50.8% | Mar 2000 | Apr 2000 | Aug 2000 | 5 months |
| −47.2% | Mar 1994 | Apr 1994 | Mar 1995 | 1 year |
| −40.8% | Jun 1995 | Jun 1995 | Apr 1996 | 10 months |